Press Releases

---------------------------------------------------------------- FOR IMMEDIATE RELEASE

CONTACTS:	César García, Chairman, President and CEO
	818-709-1244 x 7123
	-or-
	Ron Stabiner, The Wall Street Group, Inc.
	212-888-4848

IRIS INTERNATIONAL TO PRESENT AT SIDOTI & COMPANY'S 11TH ANNUAL EMERGING GROWTH INSTITUTIONAL INVESTOR FORUM

CHATSWORTH, Calif., Mar 10, 2008 - IRIS International, Inc. (NASDAQ GM: IRIS) a leading manufacturer of urinalysis systems and consumables for use in hospitals and commercial laboratories worldwide, today announced that Chairman, President and Chief Executive Officer César García will present a Company overview at Sidoti & Company's 11th Annual Emerging Growth Institutional Investor Forum at 8:30 a.m. Eastern time on Tuesday, March 25, 2008 at The Grand Hyatt Hotel in New York City.

THE COMPANY
IRIS International, Inc. (www.proiris.com), based in Chatsworth, Calif., is a leading developer, manufacturer, and marketer of medical devices, diagnostic systems and consumables. The Iris Diagnostics Division (www.irisdiagnostics.com) is a leader in automated urinalysis technology with systems in major medical institutions throughout the world. Iris Molecular Diagnostics develops innovative ultra-sensitive diagnostics and sample processing products with applications in the urinalysis, oncology and infectious disease markets. The Company's Sample Processing business unit (formerly the StatSpin^® subsidiary) (www.statspin.com), based in Westwood, Mass., manufactures innovative centrifuges and blood analysis products.